Results 31 to 40 of about 92,740 (244)

Subunit vaccines for Acinetobacter baumannii

Frontiers in Immunology, 2023
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their prevalence worldwide. Vaccines are effective tools to prevent and control A. baumannii infection.
Ning Yang, Xiao Jin, Chenghua Zhu, Fenglin Gao, Zheqi Weng, Xingran Du, Ganzhu Feng   +6 more
openaire   +3 more sources

Glycosphingolipids Recognized by Acinetobacter baumannii [PDF]

Microorganisms, 2020
Acinetobacter baumannii is an opportunistic bacterial pathogen associated with hospital-acquired infections, including pneumonia, meningitis, bacteremia, urinary tract infection, and wound infections. Recognition of host cell surface carbohydrates plays a crucial role in adhesion and enables microbes to colonize different host niches.
Miralda Madar Johansson, Mehjar Azzouz, Beatrice Häggendal, Karin Säljö, Henri Malmi, Anton Zavialov, Susann Teneberg   +6 more
openaire   +3 more sources

Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang

Jurnal Ilmu Kesehatan Indonesia, 2021
Acinetobacter baumannii is such a big challenge in this modern era because of their multi-drug resistance (MDR) through their resistance mechanism, namely the production of beta lactamase enzymes, one of them is oxacillinases.
Mhd. Alzaref, Linosefa Linosefa, Gestina Aliska   +2 more
doaj   +1 more source

Molecular Identification of Acinetobacter baumanii and Acinetobacter genomic species 13TU Using PCR

Zanco Journal of Pure and Applied Sciences, 2019
Acinetobacter baumannii is well known to be multi-drug resistant and associated with many infectins. Manual and automated identification systems, can not differentiate between both species A. baumannii and Acinetobacter genomic species 13TU.
Salah Tofik Jalal Balaky, Haval Abdulkhalik, Bashdar Mahmud Hussen, Hozan Hassan, Ahang Hasan Mawlood   +4 more
doaj   +1 more source

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii

Frontiers in Microbiology, 2014
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces ...
Vishvanath eTiwari, Monalisa eTiwari
doaj   +1 more source

Establishment and preliminary application of a rapid pathogen-specific phenotypic antibiotic susceptibility test for Acinetobacter baumannii

Di-san junyi daxue xuebao, 2021
Objective To establish a rapid phenotypic antibiotic susceptibility testing of Acinetobacter baumannii based on surfactant-propidium monoazide (PMAxx)-qPCR reaction system.
LUO Dan, LI Yuliang, WENG Bangbi, WANG Qian   +3 more
doaj   +1 more source

Core and variable components in prokaryotic genomes [PDF]

, 2011
Acinetobacter baumannii and Stenotrophomonas maltophilia are opportunistic pathogens responsable for several hospital-acquired infections. We performed Extensive comparative analyses were performed in silico to elucidate the cromosomal organization of ...
Rocco, Francesco
core   +1 more source

Revisiting Drug Resistance Mechanisms Of A Notorious Nosocomial Pathogen: Acinetobacter Baumannii [PDF]

, 2022
Mini review on mechanisms and strategies expressed by A. baumannii to resist biological compounds with antagonistic activity on their growth. Acinetobacter baumannii (A.
Phofa, Dikwata Thabiso, NOGBOU, NOEL DAVID, Musyoki, Andrew Munyalo, OBI, CHIKWELU LAWRENCE   +3 more
core   +1 more source

Acinetobacter infections: A growing threat in the hospital

Journal of Marine Medical Society, 2013
Acinetobacter baumannii is a Gram Negative coccobacilli implicated in causation of wide spectrum of nosocomial infections. Multidrug resistant Acinetobacter (MDR Acinetobacter) is emerging as an important cause of hospital acquired infections like ...
Ruby Chattopadhyay, Naveen Chawla, Ramesh Rao, Yamuna Jaikishan, Kainaz Sidhwa   +4 more
doaj   +1 more source

Artificial Intelligence‐Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae

Advanced Science, EarlyView.
Integrated artificial intelligence (AI) ensembles identify highly potent repurposed drugs against Streptococcus pneumoniae. Prospective virtual screening of 6747 drugs uncovers nine active candidates, including thiostrepton. This drug exhibits low picomolar potency and bypasses established resistance in multidrug‐resistant strains, demonstrating an ...
Joshua S. Fitch, Muhammad D. Ariadi, Min Jung Kwun, Leonie Howells, Saiveth Hernandez‐Hernandez, Nicholas J. Croucher, Pedro J. Ballester   +6 more
wiley   +1 more source